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Abstract
Mild traumatic brain injury (mTBI), or concussion, is prevalent in the military. The course of recovery can be highly
variable. This study investigates whether deployment-acquired mTBI is associated with subsequent presence and severity
of post-concussive symptoms (PCS) and identifies predictors of persistent PCS among US Army personnel who sustained
mTBI while deployed to Afghanistan. We used data from a prospective longitudinal survey of soldiers assessed 1–2
months before a 10-month deployment to Afghanistan (T0), on redeployment to the United States (T1), approximately 3
months later (T2), and approximately 9 months later (T3). Outcomes of interest were PCS at T2 and T3. Predictors
considered were: sociodemographic factors, number of previous deployments, pre-deployment mental health and TBI
history, and mTBI and other military-related stress during the index deployment. The study sample comprised 4518
soldiers, 822 (18.2%) of whom experienced mTBI during the index deployment. After adjusting for demographic, clinical,
and deployment-related factors, deployment-acquired mTBI was associated with nearly triple the risk of reporting any
PCS and with increased severity of PCS when symptoms were present. Among those who sustained mTBI, severity of
PCS at follow-up was associated with history of pre-deployment TBI(s), pre-deployment psychological distress, more
severe deployment stress, and loss of consciousness or lapse of memory (versus being ‘‘dazed’’ only) as a result of
deployment-acquired mTBI. In summary, we found that sustaining mTBI increases risk for persistent PCS. Previous
TBI(s), pre-deployment psychological distress, severe deployment stress, and loss of consciousness or lapse of memory
resulting from mTBI(s) are prognostic indicators of persistent PCS after an index mTBI. These observations may have
actionable implications for prevention of chronic sequelae of mTBI in the military and other settings.
Keywords: concussion; deployment; mental health; military; stress; traumatic brain injury
Introduction
Mild traumatic brain injury (mTBI) or concussion, previ-ously believed to be an almost uniformly benign and reversible
event, is increasingly recognized as a prelude to adverse functional
outcomes in a subset of individuals.1–4 Although most persons who
sustain mTBI recover within days to weeks with no sequelae, a sub-
group of approximately 5% of individuals experiences persistent post-
concussive symptoms (PCS) such as headaches, light or noise sensi-
tivity, dizziness, sleep problems, concentration or memory problems,
fatigue, irritability, and other somatic, cognitive, and affective symp-
toms.5Establishingprognostic indicators ofPCSandotheroutcomesof
mTBI is critical for research efforts to test preventive interventions and,
ultimately, to identify best practices for clinical care.4
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Several studies have examined predictors of persistent PCS. One
study of patients admitted to a level 1 trauma center examined
3-month outcomes of 62 patients whose traumatic injury included
mTBI and 58 patients whose traumatic injury did not include TBI.6
The mTBI did not predict persistent PCS, whereas female sex and
pre-injury depressive or anxiety disorders did. Another study of
emergency department patients evaluated 3-month outcomes of
123 patients who sustained mTBI and 100 control patients whose
injury did not involve TBI. Again, female sex and pre-morbid
psychiatric illness were predictive of PCS whereas mTBI was not.7
The failure of mTBI to predict PCS in some studies raises questions
about the specificity of PCS symptoms to the post-concussion state,
or whether these symptoms are entirely nonspecific in nature.
In the military, there have also been questions about whether
persistent PCS should be considered a consequence of mTBI or a
by-product of other factors. A cross-sectional study of United
Kingdom (UK) military personnel found that whereas self-reported
mTBI was related to subsequent PCS, self-reported exposure to
other factors (e.g., depleted uranium; helping the wounded) were
just as likely to be associated.8 More recently, a study of Canadian
military personnel similarly failed to find an association between
mTBI and PCS (after adjusting for confounders) approximately
4 months later.9
A United States (US) military study in polytrauma patients
concluded that emotional distress—but not injury-related factors—
was uniquely predictive of persistent PCS; this study, however, was
not able to assess the impact of pre-injury characteristics.10 A re-
cent systematic review of predictors of mTBI outcomes emphasizes
the prognostic value of pre-injury mental health and early post-
injury psychological symptoms (e.g., anxiety).11
In the present study, we use data from a large, prospective study of
US Army soldiers to examine the association between deployment-
related mTBI and persistent PCS approximately 3- and 9- months
later.We use pre-deployment (i.e., sociodemographic factors, mental
health status), and deployment-related (self-reported mTBI; severity
of mTBI based on whether the individual lost consciousness or was
only dazed; extent of exposure to combat stress) information, based
on the extant literature, to develop predictive models for PCS at both
follow-up time points.
We did not include in the models information about other post-
deployment disorders (e.g., post-traumatic stress disorder [PTSD]
or major depressive episode [MDE]) because it has already been
well established that there is considerable cross-sectional overlap
between the various symptom domains,12,13 and our goal here was
to predict PCS on the basis of pre-deployment and deployment-
related factors, not concurrent symptomatology. We did, however,
also evaluate models among soldiers without concurrent post-
deployment MDE or PTSD to determine whether predictors of PCS
were the same/similar in the absence of these disorders.
Methods
Overview of the Pre/Post Deployment Study (PPDS)
of the Army Study to Assess Risk and Resilience
in Servicemembers (Army STARRS)
Detailed information about the design and conduct of Army
STARRS is available in a separate report.14 The PPDS of Army
STARRS is a multiwave panel survey that collected baseline data
(T0; self-administered questionnaire [SAQ]) from US Army sol-
diers in three brigade combat teams (BCTs) during the first quarter
of 2012, within approximately 6 weeks of their deployment to
Afghanistan. Follow-up data collections for these same respon-
dents were available for this report at three times after they returned
from deployment: within 1 month of their return (T1; SAQ and
blood samples), and then approximately 3 months (T2; SAQ), and 9
months (T3; SAQ) later.
The baseline (T0) SAQ was an extensive survey of socio-
demographic characteristics, lifetime and past-30-day mental dis-
orders, and additional other potential risk and resilience factors
including but not limited to past civilian and military experiences.
The T1 follow-up SAQ included only a brief assessment of expe-
riences that occurred during deployment (including deployment
stressors and TBI). The T2 and T3 SAQ, which were virtually
identical, covered mainly subsequent experiences such as post-
concussive and other symptoms.
Participants
The PPDS study population consisted of all soldiers in three
BCTs whose members deployed to Afghanistan (average duration
of deployment was 10 months) shortly after completing the base-
line (T0) PPDS data collection. All participants gave their in-
formed, written consent to participate. These procedures were
approved by the Human Subjects Committees of all collaborating
organizations. At the baseline (T0), a total of 9949 soldiers were
present for duty in the three BCTs. Of these, 9488 (95.3%) con-
sented to participate in the survey with 8558 (86.0%) providing
complete T0 survey responses and consent to link their survey
responses to their administrative records.
The T0 longitudinal analysis cohort for this investigation was
restricted to the subpopulation (n = 7742) of these T0 study par-
ticipants who subsequently deployed to Afghanistan. A total of
4645 (60.0%) of the 7742 T0 study participants who deployed to
Afghanistan provided complete data at all three post-deployment
assessments (i.e., T1, T2, and T3).
To compensate for T1, T2, and/or T3 attrition losses from the
eligible baseline sample of 7742 participants, response propensity
(based on T0 measures available for all baseline respondents) and
post-stratification (based on comparisons of distributions for key
sociodemographic and Army career variables from administrative
data available for the entire Army as well as for survey respondents)
weighting factors15 were developed and applied in all analyses of
the multiwave data.
Finally, because this investigation focuses on sequelae of mTBI,
127 of the eligible soldiers with complete data were excluded be-
cause they met study criteria for ‘‘more-than-mild’’ (i.e., moderate
or severe) TBI (seeMeasures below). This resulted in a final sample
size of 4518 for the current analysis.
Measures
Baseline (T0) assessment. At baseline (T0), PPDS respon-
dents self-administered a computerized version of the Composite
International Diagnostic Interview screening scales (CIDI-SC)16 to
assess 10 lifetime Diagnostic and Statistical Manual of Mental
Disorders, 4th edition mental disorders. The sum of all past 30-day
depression, anxiety, and irritability items from the screening scales
(24 items each ranging 0–4) was calculated to create a past-month
general distress score (range 0–96). Also collected at the T0 as-
sessment were sociodemographic information and a query about
previous TBI(s). The latter was assessed by a series of questions
similar to those described below for the T1 assessment. For pur-
poses of the analyses described here, any pre-deployment reporting
of probable TBI of any level of severity was counted as being
positive for probable TBI history before the index deployment.
First post-deployment (T1) assessment
Deployment stress. The T1 survey included 15 questions
that assessed the frequency of specific deployment experiences that
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were stressful or traumatic in nature [e.g., During your deployment
how many times did you.Go on combat patrols or have other
dangerous duty (e.g., route clearance, clearing buildings, dis-
arming civilians, working in areas that had improvised explosive
devices)? or.Fire rounds at the enemy or take enemy fire (either
direct or indirect fire)?]. Responses to these questions were dis-
cretized (yes/no), and positive responses were summed to create a
total (0–15) deployment stress severity score.
Deployment-acquired TBI. Probable TBI was determined by
the probe [How many times during your recent deployment did you
have a head, neck, or blast injury that.] followed by a series of
questions pertaining to alteration or loss of consciousness (LOC)
and lapse of memory that followed. We used the highest level of
severity of response(s) to characterize each respondent as having
had one of: (1) No TBI; (2) probable ‘‘very mild’’ TBI (alteration
but no LOC [‘‘didn’t knock you out but caused you to be dazed or
‘see stars’’’] and no lapse of memory); (3) probable ‘‘mTBI’’ (LOC
[‘‘knocked you out’’] for less than 30min and/or lapse of memory
for less than 30min); or (4) probable ‘‘more-than-mTBI’’ (LOC for
30min or more or lapse in memory lasting 30min or more).
Using these criteria, TBIs classified as very mild or mild would
match up with most standard and widely used definitions of mTBI
(e.g., http://tbilaw.com/acrm-brain-injury-definition.html). The
majority of TBIs classified as more-than-mild would fall into a
higher category (i.e., moderate or severe) of clinical severity and
were therefore not included in the present analyses. We evaluated
the effects of level of mTBI severity (i.e., very mild vs. mild), as
well as ‘‘any’’ deployment-acquired mTBI compared with none.
Second (T2) and third (T3) post-deployment assessments
PCS. Included at T2 and again at T3 were eight items that
reflect the array of PCS: balance problems or dizziness; sensitivity
to noise; sensitivity to light; memory problems; irritability; dif-
ficulty concentrating; headaches; and feeling tired out or being
easily fatigued. Past 30-day occurrence of these symptoms was
assessed in a survey section that inquired generally about ‘‘health
problems’’ without any reference to TBI or other injury or event.
Respondents rated each symptom on a 5-point frequency scale
that ranged from ‘‘None of the time (0)’’ through ‘‘All or almost
all of the time (4).’’
Summing these ratings yielded an eight-item PCS score (PCS-8)
ranging from 0–32, with good internal consistency (Cronbach al-
pha = 0.88). For the purpose of sensitivity analysis, we also calcu-
lated an alternative PCS measure (PCS-5; range = 0–20) that
excluded symptoms that are also commonly associated with anxi-
ety and depressive disorders (i.e., irritability, difficulty concen-
trating, and feeling tired or easily fatigued).
Statistical methods
Using the total sample (N = 4518), we conducted zero-inflated
negative binomial (ZINB) regression analyses to jointly model the
effect of predictors of interest on presence (yes/no) and severity (for
nonzero scores) of PCS symptoms (as measured by the PCS-8) at
T2 and T3, respectively. Some of the predictors of interest were
assessed before the index deployment; these were age (30-or-
younger vs. older), sex, race (white vs. black vs. Asian vs. other),
ethnicity (Hispanic vs. other), number of previous deployments
(none vs. one vs. two or more), previous lifetime TBI, and pre-
deployment past-month general distress.
Two additional predictors reflected experiences during the index
deployment and were collected immediately on return to the United
States at T1; these were severity of deployment stress and
deployment-acquired mTBI. BCT was also dummy-coded and
adjusted for in the analyses. Duration of index deployment and the
interaction of lifetime TBI and deployment-acquired mTBI were
included in preliminary models but did not predict PCS and were
thus excluded from the final models.
In the subsample of soldiers who reported mTBI during the
index deployment (n= 822), linear regression was conducted to
evaluate associations between the pre- and peri-deployment factors
listed above and severity of PCS (as measured by the PCS-8) at T2
and T3. Given that all soldiers in the subsample had sustained
mTBI, level of severity of deployment-acquired TBI (very mild vs.
mild) was entered as a predictor instead of any mTBI versus none.
To evaluate the robustness of findings, all ZINB and linear re-
gression analyses were repeated using PCS-5 (see Measures) as the
outcome. This sensitivity analysis was conducted to evaluate the
possibility that observed associations between mTBI and PCS were
attributable to symptoms that could also be explained by co-
occurring anxiety or depression. An additional set of sensitivity
analyses were conducted by excluding persons with concurrent
MDE or PTSD. The purpose of this set of analyses was to determine
whether the observed associations between mTBI and PCS were
attributable to the presence of these comorbid mental health con-
ditions.
All analyses were weighted to account for T1, T2, and T3 survey
attrition from the eligible T0 soldier cohort. Because the PPDS data
are both clustered by BCT and administration session and weigh-
ted, the design-based Taylor series linearization method was used
to estimate standard errors. Multivariate significance was examined
using design-based Wald c2 tests. All statistical analyses were
conducted using the software R (version 3.0.2; R Development
Core Team, 2011) or STATA Version 14.0. The p values less than
0.05 (two-tailed) were considered statistically significant.
Results
Participant characteristics at pre-deployment
baseline (T0)
All reported percentages and means are weight-adjusted. The
sample was predominantly male (94.7%, standard error [SE]= 0.6%)
and less than 30 years of age (71.5%, SE= 1.4%). The majority of
participants were white (71.8%, SE= 0.9%), with smaller propor-
tions identifying their race as other (12.2%; SE= 0.6%), black
(12.0%; SE= 0.7%), and Asian (4.0%; SE= 0.3%); and 16.0%
(SE= 0.7%) identifying their ethnicity as Hispanic. For 44.8%
(SE= 1.3%) of soldiers, the index deployment to Afghanistan was
their first, with others reporting one (23.1%, SE= 0.7%) or multiple
(32.0%, SE= 1.1%) previous deployments.
Before the index deployment, mean past month general distress
was 10.97 (standard deviation [SD]= 14.50; median 6, range 0–96;
interquartile range [IQR] = 2–13). Approximately one-third of
soldiers reported having sustained TBI(s) before the index de-
ployment (34.0%; SE= 1.0%).
Deployment stress and deployment-acquired TBI
The mean number of deployment stressors in the index de-
ployment endorsed by respondents at T1 was 3.97 (SD = 2.74;
median 4, range 0–15, IQR = 2–6). Nearly one in five soldiers re-
ported having sustained probable mTBI(s) during the index de-
ployment with 13.3% (SE= 0.6%) endorsing probable very mild
TBI (i.e., dazed only, no LOC or amnesia) and 4.8% (SE= 0.4%)
endorsing probable mild TBI.
Post-concussive symptoms at T2 and T3
At the T2 follow-up, the mean PCS-8 score was 12.26 (SD= 7.31,
median= 11, IQR= 7–17) in soldiers with a deployment-acquired
mTBI (n= 822) vs. 7.74 (SD= 6.22, median= 7, IQR= 3–11) in
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those without a deployment-acquired mTBI (n= 3696; p< 0.0001).
At the T3 follow-up, the mean PCS-8 score was 10.31 (SD= 6.96,
median= 10, IQR= 5–15) in soldiers with a deployment-acquired
mTBI (n= 822) vs. 6.76 (SD= 6.31, median= 5, IQR= 2–11) in
those without a deployment-acquired mTBI (n= 3696; p< 0.0001).
Prognostic indicators of PCS in the total sample
T2 Follow-up. In a ZINB regression adjusting for age group,
race, ethnicity, BCT, and number of previous deployments, it was
observed that worse pre-deployment general distress, more severe
deployment stress during the index deployment, and having sus-
tained an mTBI during the index deployment, were all significantly
associated with increased odds of nonzero score on the PCS-8 (i.e.,
having some post-concussive symptoms vs. none; see AORs for ‘‘3
months post-deployment [T2]’’ in Table 1], as well as with sig-
nificant increases in PCS-8 score when symptoms were present
(i.e., higher score when PCS-8 score was nonzero; see FCs for ‘‘3
months post-deployment [T2]’’ in Table 1). Female sex and history
of TBI before the index deployment also were significantly asso-
ciated with increased PCS-8 score when symptoms were present
(Table 1).
T3 Follow-up. In a ZINB regression adjusting for age group,
race, ethnicity, BCT, and number of previous deployments, it was
observed that pre-deployment history of TBI, worse pre-deployment
general distress, more severe deployment stress during the index
deployment, and having sustained an mTBI during the index de-
ployment were all significantly associated with increased odds of
nonzero score on the PCS-8 (i.e., having some post-concussive
symptoms vs. none; see AORs for ‘‘9 months post-deployment
[T3]’’ in Table 1) as well as with significant increases in PCS-8 score
when symptoms were present (i.e., higher score when PCS-8 score
was nonzero; see FCs for ‘‘9 months post-deployment [T3]’’ in
Table 1). Female sex also was associated with higher score on the
PCS-8 when symptoms were present (Table 1).
Prognostic indicators of PCS in soldiers who sustained
mTBI during the index deployment
Having established that mTBI during the index deployment was
a strong predictor of PCS symptoms at follow-up, we next deter-
mined whether severity of mTBI (i.e., very mild [‘‘dazed only’’] vs.
mild [including LOC and/or lapse in memory]) influenced PCS
outcomes. Among soldiers who had sustained an mTBI during the
index deployment (n= 822), including the same covariates as in the
model above, having had a mild versus very mild TBI during de-
ployment was significantly associated with increased PCS-8 score
at T2 and at T3 (Table 2). History of TBI before the index de-
ployment, worse pre-deployment past-month general distress, and
more severe deployment stress also predicted higher PCS-8 score at
T2 and at T3 (Table 2).
Sensitivity analyses with PCS-5
When ZINB regression models of PCS were rerun with PCS-5 as
the outcome, deployment-acquired mTBI remained a highly signif-
icant predictor of presence and severity of PCS at follow-
up.Magnitudes of associations were comparable to those observed in
the PCS-8 models, except at T2, deployment-acquired TBI appeared
an even stronger predictor of nonzero score on PCS-5 (AOR= 3.85;
95% CI 2.20–6.73; p< 0.001; cf. Table 1). The other predictors of
interest displayed associations with PCS-5 that were similar to those
they had with PCS-8. Exceptions were that presence of PCS-5
symptoms at T2was additionally predicted by history of lifetimeTBI
(AOR= 1.50; 95% CI 1.08–2.09; p= 0.018), but not significantly
predicted by deployment stress severity ( p= 0.081); and presence of
PCS-5 symptoms at T3 was additionally predicted by female sex
(AOR= 2.22; 95% CI 1.38–3.60; p= 0.002). Also contrasting with
the PCS-8 results was the finding that severity of symptoms on PCS-
5 was not significantly predicted by sex at T2 ( p= 0.11; cf. Table 1).
When linear regression models of PCS-5 were run in the sub-
sample of soldiers who sustained deployment-acquired mTBI, re-
sults were comparable to those of the PCS-8 models. Severity of
Table 1. Results of Weighted Zero-Inflated Negative Binomial Regression Evaluating Effects of Sex,
Pre-Deployment General Distress, Pre-Deployment Traumatic Brain Injury History, Deployment Stress Severity,
and Deployment-Acquired Traumatic Brain Injury* on Presence (Yes/No; Adjusted Odds Ratio) and Severity
(for Nonzero Scores; Fold Change) of Post-Deployment Post-Concussive Symptoms in Soldiers
With and Without Mild Traumatic Brain Injury (n = 4518)
3 months post-deployment (T2) 9 months post-deployment (T3)
AORa 95% CI p FCb 95% CI p AORa 95% CI p FCb 95% CI p
Female sex 1.34 0.50–3.58 0.551 1.19 1.07–1.33 0.002 1.46 0.91–2.32 0.110 1.23 1.10–1.37 0.001
Pre-deployment past-month
general distress
1.39 1.11–1.73 0.005 1.01 1.01–1.01 <0.001 1.14 1.06–1.22 0.001 1.01 1.01–1.01 <0.001
Deployment stress severity 1.09 1.00–1.19 0.050 1.05 1.04–1.06 <0.001 1.10 1.04–1.16 0.001 1.04 1.03–1.05 <0.001
Any lifetime pre-deployment
TBI
1.34 0.91–1.98 0.133 1.10 1.05–1.15 <0.001 1.59 1.19–2.11 0.002 1.10 1.03–1.17 0.004
Any deployment-acquired
mild TBI
2.88 1.64–5.05 <0.001 1.31 1.24–1.39 <0.001 2.92 1.82–4.68 <0.001 1.23 1.16–1.31 <0.001
AOR, adjusted odds ratio; CI, confidence interval; FC, fold change. Post-concussive symptoms (PCS) were measured with the PCS-8, which assessed
severity of: balance problems or dizziness, sensitivity to noise, sensitivity to light, memory problems, irritability, difficulty concentrating, headaches, and
feeling tired out or being easily fatigued.
*Models also adjust for age group (<30 years vs. older), race, ethnicity, brigade combat team, and number of previous deployments.
aFor ease of interpretation, AORs reported in the table indicate odds of a nonzero score on the PCS-8 (i.e., presence of any symptoms) that are
associated with each hypothesized predictor. These AORs were calculated by taking the inverse of the AORs for odds of a zero score (not shown in
Table).
bFCs indicate the fold increase or decrease in PCS-8 score associated with each predictor when any symptoms are present (i.e., when PCS-8 score is
nonzero).
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mTBI (very mild vs. mild) during the index deployment remained a
highly significant predictor of PCS severity at T2 (B= 2.03;
SE = 0.44; t = 4.57; p < 0.001) and at T3 (B= 1.71; SE = 0.43;
t = 3.98; p = 0.001). The only notable discrepancy with the PCS-8
models was that the association of lifetime TBI with PCS-5 score at
T2 slightly exceeded the threshold for statistical significance
(B = 0.55; SE = 0.27; t = 2.05; p= 0.052).
Sensitivity analyses among soldiers without concurrent
post-deployment MDE or PTSD
A parallel set of analyses was conducted excluding soldiers in
whom MDE or PTSD had developed at T2 or T3, respectively.
With these models (data not shown), the only minor difference is
that when MDE/PTSD subjects are excluded, the p values for ef-
fects of deployment stress climb just above the threshold for sig-
nificance for the T2 ZINB model of PCS in the full sample
( p = 0.07); and for the two linear regression models of PCS in the
subgroup exposed to mTBI ( p= 0.07 for T2; p= 0.06 for T3).
Discussion
In this prospective, longitudinal study of US soldiers surveyed
before and subsequent to an average 10-month deployment to Af-
ghanistan, we found clear evidence that mTBI predicted persistent
PCS. Further support for this association comes from the finding of
a dosage effect wherein soldiers with mTBI that involved LOC or
lapse in memory had more severe PCS than those whose mTBI
involved only alteration in consciousness (i.e., being dazed).
Confidence in these findings is enhanced by sensitivity analyses
that confirmed these effects using a more conservative measure of
PCS (i.e., excluding symptoms that are also defining features of
anxiety and mood disorders).
The current findings stand in contrast to some (but not most)
studies of military personnel that have found mTBI to be no more
predictive of PCS than other nonbrain injury factors.6–9 This lit-
erature may be influenced by a type of publication bias wherein
studies that fail to find an association between mTBI and PCS are
published, given how apparent this association would otherwise
seem to be. Our finding that sustaining mTBI during an index de-
ployment was indeed a determinant of presence and severity of PCS
at 3 and 9 months post-deployment highlights the need for con-
tinued investigation of persistent PCS as a potential sequela of
mTBI.
This study also aimed to identify risk factors for persistent PCS
among persons who sustained mTBI during deployment. A vari-
ety of potential risk factors have been examined, ranging from
genetic factors, such as apolipoprotein E epsilon-4 allele17 to
neurocognitive and imaging parameters (e.g., diffusion tensor
imaging),18 none of which has yet been well replicated or shown
to be conclusively predictive. Other blood-based biomarkers are
also being evaluated,4 some of which may eventually be con-
firmed as predictive biomarkers of PCS (e.g., serum Tau-A or
SNTF).19,20
In this study, we focused on risk factors for which there is a
consistent precedent in the literature,11 and indeed confirmed that
previous TBI(s) and pre-injury (or, in this military context, pre-
deployment) psychological distress predicted increased severity of
PCS at follow-up. Importantly, extent of deployment-related stress
also was a predictor of PCS, suggesting that the degree of stress
exposure also contributes to PCS and that the implementation of
buffers to these stresses may be an avenue toward prevention. As
has been noted in some studies, female sex was also associated with
increased risk of poor recovery from mTBI.21
We did not look at sleep disturbance, per se, as a specific pre-
dictor of PCS. Given recent findings that sleep difficulties pre- and
post-injury were predictive of poorer functional outcomes in a
cohort of adults with mTBI,22 future research should pay special
attention to insomnia as a potential intervention target.
Strengths of this study are its large sample size and its detailed,
systematic longitudinal prospective assessment of three Army
BCTs about to be deployed to Afghanistan. Another strength is the
way the questions about PCS were asked: they were included in a
separate survey section from the questions about mTBI and, in fact,
were not asked about in the context of having experienced a TBI.
This aspect of the survey design may have mitigated the tendency
for persons who reported mTBI to then go on to identify symptoms
as a result of that injury.
Our study also has a number of limitations. First and foremost
is the reliance on self-report for reporting of mTBI. Whereas
external and independent corroboration of mTBI is desirable, it is
rarely achievable in this type of study. In fact, our review of
medical records suggested that only a small fraction of TBIs were
captured in the medical administrative data, and most of these
were moderate to severe. This is the nature of mTBI in general,
and perhaps particularly in the military, where most mTBIs are
undocumented.23
Table 2. Results of Linear Regression Evaluating Effects of Sex, Pre-Deployment Psychological Distress,
Pre-Deployment Traumatic Brain Injury History, Deployment Stress Severity, and Severity
of Deployment-Acquired Traumatic Brain Injury* on Post-Deployment Post-Concussive Symptoms
in Soldiers with Mild Traumatic Brain Injury (n = 822)
3 months post-deployment (T2) 9 months post-deployment (T3)
B SE B t p B SE B T p
Female sex -0.33 1.43 -0.23 0.82 -0.22 1.20 -0.18 0.86
Pre-deployment past-month general distress 0.16 0.01 11.68 < 0.001 0.10 0.01 7.87 <0.001
Deployment stress severity 0.40 0.11 3.66 0.001 0.34 0.09 3.76 0.001
Any lifetime pre-deployment TBI 1.03 0.43 2.40 0.025 1.08 0.44 2.43 0.023
Deployment-acquired TBI involved LOC or amnesia
(versus ‘‘dazed’’ only)
2.48 0.65 3.80 0.001 2.40 0.67 3.60 0.002
TBI, traumatic brain injury; LOC, loss of consciousness.
Post-concussive symptoms (PCS) were measured with the PCS-8, which assessed severity of: balance problems or dizziness, sensitivity to noise,
sensitivity to light, memory problems, irritability, difficulty concentrating, headaches, and feeling tired out or being easily fatigued.
*Models also adjust for age group (<30 years vs. older), race, ethnicity, brigade combat team, and number of previous deployments.
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Another potential limitation is the absence of information in the
survey about blast versus nonblast mechanisms of injury. A recent
study suggests, however, that adverse functional outcomes in TBI
may have little to do with mechanism (blast v. non-blast) of inju-
ry.24 Still, this and other injury-related factors such as co-occurring
extracranial injury—which, along with pre-existing mental health
conditions has been found to predict poor outcome after mTBI25—
may well be important and should be considered in future studies.
A third potential limitation has to do with the timing of admin-
istration of the survey questions about mTBI. A recent study of UK
military personnel suggests that in-theater reporting of TBI yields
lower rates than when reporting takes place post-deployment.26 We
attempted to mitigate recall bias by asking about deployment-
related mTBI very early on (1–2 days) after redeployment to the
United States. Whether or not the timing of reporting of mTBI
influenced the findings is a subject for future study. A fourth po-
tential limitation is our use of a novel measure of PCS for this study.
Additional psychometric work is needed to ensure that this measure
is a valid and longitudinally reliable indicator of PCS severity.
Worthy of further study is the frequent finding that PCS and
post-traumatic stress symptoms are often seen in tandem as se-
quelae to mTBI. Interestingly, many of the prospective risk factors
for post-traumatic stress symptoms after TBI also have been found
to be risk factors for PCS; these include female sex, pre-injury
mental health status, and extent of deployment-related stress.27
Given the striking similarity of risk factors, these observations
should encourage additional research into shared pathophysiolog-
ical mechanisms (e.g., inflammatory)28 for PCS and post-traumatic
stress symptoms.
What are potentially actionable implications of our findings
beyond those pertaining to predictive analytics for PCS? Our re-
sults show that persons with more severe mTBI (i.e., with LOC or
amnesia), previous history of TBI, pre-injury mental health
symptoms, and more severe stress surrounding the TBI are more
vulnerable to PCS, implying that patients with TBI presenting with
one or more of these features may comprise the ideal group for
targeted prevention or early intervention efforts. Previous history of
TBI, which for many soldiers in this study originated in pre-
military concussions sustained from sports or other injuries, is es-
pecially prevalent and worthy of further attention as a vulnerability
factor for PCS.
The optimal approach to prevention and early intervention,
however, is yet to be determined.29 Interestingly, a recent ran-
domized controlled trial (RCT) of strict rest versus usual care after
acute concussion (in 11–22-year-olds) found no benefit (on balance
or neurocognitive outcomes) of strict rest and, in fact, some evi-
dence of harm because those assigned to acute rest reported more
PCS.30 A potential explanation is that strict rest provides an op-
portunity to focus on existing symptoms and thereby intensify
them. Indeed, a recent review suggests that excessive prescription
of rest may result in attentional biases and symptom misattribution
that can worsen PCS.31
These observations raise the question of whether or not
cognitive-behavioral therapies and related attention-modifying
approaches would be useful for patients with TBI at risk for per-
sistent PCS. Patients with pre-injury emotional disorders, symp-
toms of anxiety/depression early in the post-injury period, or severe
life stress (i.e., those predicted to have increased odds of PCS de-
veloping based on our findings) are likely more vulnerable to
threat-focused attentional biases and catastrophic interpretations of
symptoms32 and would be hypothesized to derive particular benefit
from these treatment approaches.
Such interventions also could alleviate symptoms of stress and/or
emotional disorders, producing additional clinical benefits. Indeed,
findings from a recently published RCT suggest that cognitive be-
havioral therapy is effective for reducing anxiety and depression
symptomsafterTBI.33Given thepreviousfindingof increasedPCS in
patients prescribed rest after mTBI,30 however, it would be important
to also monitor for potential adverse effects of increasing focus on
symptoms through certain elements of cognitive-behavioral or
attention-modification treatments (e.g., self-monitoring). These hy-
potheses merit evaluation in future experimental studies and RCTs.
Conclusion
Data from a prospective, longitudinal study of US soldiers (sur-
veyed pre- and post-deployment) provided evidence that mTBI is a
determinant of persistent PCS. Moreover, a dosage effect was ob-
served wherein soldiers with mTBI that involved LOC or lapse in
memory reported more severe PCS than those whose mTBI involved
only alteration in consciousness (i.e., being dazed). The current study
also replicates and extends previous work on predictors of PCS by
identifying history of previous TBI, worse pre-injury mental health
status, and acute stress (in this case, deployment stress) as key
prognostic factors in the development of persistent PCS after an
index TBI.
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